Observational studyPloS one2018

HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.

Jorge Valencia La Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.